Charles River Acquires Agilux

Boston – October 11, 2016 – Cooley advised Charles River Laboratories on its acquisition of Agilux Laboratories for $64 million. 

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions accelerate their research and drug development efforts. Agilux is a contract research organization that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic services and pharmacology services.

“Agilux reinforces the linkage between our discovery and safety assessment capabilities, and provides clients with a comprehensive testing solution that spans their discovery and regulated drug development needs,” said James Foster, CEO of Charles River in a company press release.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Lester Fagen  Senior Counsel Boston
Miguel J. Vega  Partner Boston
Mike Faber  Retired Partner San Francisco
Michael Tuscan  Partner Washington, DC
Kathleen Goodhart  Partner San Francisco
Natasha Leskovsek  Of Counsel Washington, DC
Heather Harrington  Special Counsel Boston
Kristin Leavy  Special Counsel Washington, DC
Jonathan Rivinus  Partner Colorado
Andrew Keith  Special Counsel Washington, DC
Kristine Forderer  Partner San Francisco
Christopher Kimball  Partner Washington, DC
Rebecca Ross  Special Counsel Washington, DC